Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma – Nature Cancer vm_adminJanuary 14, 2025 Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UKDhruva Biswas, Yun-Hsin Liu, David A. Moore, Takahiro Karasaki, Kristiana Grigoriadis, Selvaraju Veeriah, Cristina Naceur-Lombardelli, Neil Magno, Sophia Ward, Alexander M. Frankell, Ariana Huebner, Corentin Richard, Crispin T. Hiley, Emilia L. Lim, Francisco Gimeno-Valiente, Krupa Thakkar, Maise Al Bakir, Monica Sivakumar, Ieva Usaite, Sadegh Saghafinia, Sharon…Article Source https://www.nature.com/articles/s43018-024-00883-1 Facebook Twitter Pinterest LinkedIn Digg Tumblr Reddit Buffer Blogger Newsvine HackerNews Flipboard Share LiveJournal Yammer Mix Instapaper Copy Link Mastodon
Oracle’s $248 billion rent is another AI bombshellBy Chris Bryant Publication Date: 2025-12-16 10:00:00 Of all the eye-popping numbers that Oracle Corp. last week about the costs…
TikTok deal forms new US entity with investors Oracle and Silver Lake | The North State JournalBy Barbara Ortutay Publication Date: 2025-12-27 17:00:00 TikTok will spin off a new US-based company controlled by American investors, allowing…
Oracle Veteran Appointment Sends CID HoldCo Shares Up Nearly 24% After-Hours – CID Holdco (NASDAQ:DAIC)By Mohd Haider Publication Date: 2025-12-24 08:40:00 CID HoldCo Inc. (NASDAQ:DAIC) Shares rose 23.80% to $1.04 in after-hours trading on…